Opioid Use among People with Migraine: Results of the OVERCOME (US) Study
Abstract Introduction: Despite expert recommendations against using opioids for migraine treatment, their use remains common in the USA. We aimed…
Abstract Introduction: Despite expert recommendations against using opioids for migraine treatment, their use remains common in the USA. We aimed…
Abstract The American Migraine Foundation estimates that over 39 million Americans and over 1 billion people worldwide suffer from some…
Abstract Background: Calcitonin gene-related peptide (CGRP) release from trigeminal structures is central to migraine pathophysiology. This study employed an ex…
Abstract Supplementary Information: The online version contains supplementary material available at 10.1038/s41598-024-74754-1. Article type: Research Article Keywords: Cannabis use disorder,…
Abstract Background and Objectives: Primary headaches are highly prevalent among medical students, negatively impacting their health and academic performance. Excessive…
Abstract Cannabidiol (CBD) is the main pharmacologically active phytocannabinoid. CBD exerts an analgesic effect in several pain models, does not…
Abstract Medical marijuana treatment for migraine is becoming more common, although the legality and societal acceptance of marijuana for medical…
Abstract The endocannabinoid system (ECS) influences many biological functions, and hence, its pharmacological modulation may be useful for several disorders,…
Abstract Cannabis has been long used since ancient times for both medical and recreational use. Past research has shown that…
Abstract Background and purpose: This study was undertaken to investigate migraine prevalence in persons with hallucinogen persisting perception disorder (HPPD)…